Summary
The Indian government proposes easier norms for drug approval processes, allowing applicants to begin studies after informing the regulator and halving import license processing times to 45 days. This initiative aims to enhance the ease of doing business in the pharmaceutical sector, though stringent requirements will remain for high-risk drug categories.